Evidence map›Paper›PMID 11827906›Full record

ArticleArchives of disease in childhood2002

Impact of antiretroviral protocols on dynamics of AIDS progression markers.

S Resino, J M Bellón, S Sánchez-Ramón, D Gurbindo, J Ruiz-Contreras, J A León, J T Ramos, M A Muñóz-Fernández

Abstract readMulticenter Study
In one paragraph

Article in Archives of disease in childhood, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

S ResinoDepartment of Immunology, General University Hospital "Gregorio Marañón", Madrid, Spain.
J M Bellón
S Sánchez-Ramón
D Gurbindo
J Ruiz-Contreras
J A León
J T Ramos
M A Muñóz-Fernández

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo assess the "real life" effectiveness of different antiretroviral therapies (ART).

methodsA retrospective multicentre observational study in 150 HIV-1 vertically infected children on the progression to AIDS (study A), and in 61 HIV-1 infected children on the evolution of the most relevant markers of progression (study B). All children were categorised into four groups: untreated (NT); on monotherapy (MT); on combination therapy (dual-ART); and on potent ART (HAART).

resultsNo child in the HAART group progressed to AIDS, whereas 14 children in the NT and seven in the MT groups progressed to AIDS, respectively, the differences being statistically significant. There was a mean increase of 8 units of %CD4+ per year; this was greater in the HAART group than in the other groups. The mean decrease in viral load was 0.65 log(10) copies/ml per year; this was greater in the HAART group than in the NT and MT groups. The HAART group had the lowest probability of returning to baseline %CD4+ and viral load.

conclusionPotent ART had the greatest protective effect against progression to AIDS in this observational study.

Indexed as

HIV-1Acquired Immunodeficiency SyndromeAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveBiomarkersCD4 Lymphocyte CountChildChild, PreschoolDisease ProgressionFemaleHIV InfectionsHumansLinear ModelsLongitudinal StudiesMaleProportional Hazards ModelsAnti-HIV AgentsBiomarkers

Identifiers

PMID11827906
PMCPMC1761061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.